Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label previous answer version answering member constituency answering member printed answering member
tabling member	label

Search

1491169

	registered interest
	date	20/07/2022
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Evusheld
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what plans his Department has to facilitate the availability of Evusheld over the counter at pharmacies rather than by prescription from a GP.
	tabling member constituency	Ealing Central and Acton
	tabling member printed	Dr Rupa Huq
	uin	40863
	answer	answer is ministerial correction date of answer 13/10/2022 answer text <p>The decision not to procure Evusheld at this time for prevention through emergency routes is based on independent clinical advice by the multi-agency RAPID C-19 and a national expert policy working group. The decision is based on a range of evidence, including clinical trial data, in vitro analysis and emerging observational studies. RAPID C-19 monitors activity in clinical trials for emerging evidence and where treatments are proven to be clinically effective, enables access for National Health Service patients. The Chief Medical Officer for England is content that the correct process for providing clinical advice has been followed and it should now be referred to the National Institute for Health and Care Excellence for further evaluation. The Antivirals and Therapeutics Taskforce has published this analysis of evidence, which is available at the following link:</p><p><a href="https://www.gov.uk/government/publications/rapid-c-19-oversight-group-report-to-chief-medical-officer-review-of-evusheld" target="_blank">https://www.gov.uk/government/publications/rapid-c-19-oversight-group-report-to-chief-medical-officer-review-of-evusheld</a></p><p>A letter was issued to patient groups on 5 September on the evidence and expert analysis for the decision, which is available at the following link:</p><p><a href="https://www.gov.uk/government/publications/decision-on-evusheld-as-a-coronavirus-covid-19-treatment-letter-to-patient-groups" target="_blank">https://www.gov.uk/government/publications/decision-on-evusheld-as-a-coronavirus-covid-19-treatment-letter-to-patient-groups</a></p> answering member constituency Newark answering member printed Robert Jenrick question first answered 13/10/2022 14:51:31 answering member 4320 label Biography information for Robert Jenrick
	tabling member	4511 label Biography information for Dr Rupa Huq

1503288

	registered interest
	date	02/09/2022
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Diagnosis
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 9 December 2021 to Question 85238 on Diagnosis, when he plans to publish NHS England’s evaluation report on Rapid Diagnostic Centres.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	44955
	answer	answer is ministerial correction date of answer 27/09/2022 answer text <p>The National Health Service cancer programme commissioned an external evaluation of the faster diagnosis programme, including rapid diagnostic centres, for the period until March 2024. The final report will be considered for publication in 2024.</p> answering member constituency Newark answering member printed Robert Jenrick question first answered 27/09/2022 14:59:49 answering member 4320 label Biography information for Robert Jenrick
	tabling member	3960 label Biography information for Henry Smith

1503384

	registered interest
	date	02/09/2022
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Evusheld
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, if he will publish (a) the full clinical and scientific advice that his Department received on Evusheld and (b) his Department's reasoning for its decision not to procure the drug for treatment of long covid-19.
	tabling member constituency	Denton and Reddish
	tabling member printed	Andrew Gwynne
	uin	45044
	answer	answer is ministerial correction date of answer 27/09/2022 answer text <p>The Government has decided not to procure Evusheld for prevention through emergency routes at this time. This is a decision based on independent clinical advice by the multi-agency initiative, RAPID C-19 and a national expert policy working group. These groups considered a range of evidence, including clinical trial data, in vitro analysis and emerging observational studies and concluded there is currently insufficient evidence of benefit to recommend deployment. The Chief Medical Officer for England is content that the correct process for providing clinical advice has been followed and agree that this should now be referred to the National Institute for Health and Care Excellence for further evaluation.</p><p>The Department wrote to patient groups on 5 September 2022 with information on this decision and evidence considered. The letter summarised the evidence considered by RAPID C-19 which contributed to the decision not to procure and deploy Evusheld and detailed the next steps the Government will take. The Department intends to publish further details of the clinical advice received shortly.</p> answering member constituency Newark answering member printed Robert Jenrick question first answered 27/09/2022 15:02:05 answering member 4320 label Biography information for Robert Jenrick previous answer version 17526 answering member constituency Erewash answering member printed Maggie Throup answering member 4447
	tabling member	1506 label Biography information for Andrew Gwynne

1503413

	registered interest
	date	02/09/2022
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Attention Deficit Hyperactivity Disorder: Medical Treatments
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to help ensure that patients who require treatment for Attention deficit hyperactivity disorder and similar conditions will not been impacted by potential disruptions to the supply chains for the prescription medications they require.
	tabling member constituency	Leeds North West
	tabling member printed	Alex Sobel
	uin	45098
	answer	answer is ministerial correction date of answer 27/09/2022 answer text <p>The Department has well established procedures to deal with supply issues with prescription medicines and works with the Medicines and Healthcare products Regulatory Agency, NHS England and industry to prevent shortages and ensure that any risks to patients are minimised should they arise.</p><p>We are aware of supply issues with some medicines used in the treatment of attention deficit hyperactivity disorder. However, alternative products remain available and communications have been issued to the National Health Service to provide advice.</p> answering member constituency Newark answering member printed Robert Jenrick question first answered 27/09/2022 15:36:57 answering member 4320 label Biography information for Robert Jenrick
	tabling member	4658 label Biography information for Alex Sobel

1503433

	registered interest
	date	02/09/2022
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Health Services: North West
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what recent progress his Department has made on tackling backlogs in NHS provision in the North-West as a result of the outbreak of covid-19.
	tabling member constituency	Southport
	tabling member printed	Damien Moore
	uin	45130
	answer	answer is ministerial correction date of answer 27/09/2022 answer text <p>In the North West, the number of people waiting two years or more for treatment has been reduced by 86% between January and June 2022.</p><p>The ‘Delivery plan for tackling the COVID-19 backlog of elective care’ commits the National Health Service to deliver nine million additional treatments and diagnostic procedures over the next three years and approximately 30% more elective activity by 2024/25, compared to pre-pandemic levels. We have allocated more than £8 billion to support the delivery plan, in addition to the £2 billion Elective Recovery Fund.</p> answering member constituency Newark answering member printed Robert Jenrick question first answered 27/09/2022 13:58:05 answering member 4320 label Biography information for Robert Jenrick
	tabling member	4669 label Biography information for Damien Moore

1503520

	registered interest
	date	02/09/2022
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Ambulance Services: Dorset
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to tackle increased waiting times for ambulances in Dorset.
	tabling member constituency	Bournemouth East
	tabling member printed	Mr Tobias Ellwood
	uin	45170
	answer	answer is ministerial correction date of answer 27/09/2022 answer text <p>NHS England advice that there are a range of interventions to address increased waiting time for ambulances in Dorset. These measures aim to improve the flow of patients through accident and emergency departments, reduce waiting times and delays in the transfer of patients from ambulances and allow crews to respond to calls more efficiently.</p><p>This includes the earlier identification of patients needing complex discharge support and ensuring multi-disciplinary engagement in the discharge plans to increase bed capacity. An expected date of discharge is determined within 48 hours of admission. The operation of transfer of care hubs is being streamlined and demand and capacity modelling for local and community systems is being developed.</p><p>NHS England has allocated an additional £150 million for ambulance service pressures in 2022/23, supporting improvements to response times through additional call handler recruitment, retention and other funding requirements. A further £20 million has been invested in the upgrade of the ambulance fleet by reducing its age profile and fuel emissions while increasing productivity and capacity. Additionally, St John Ambulance has been contracted to deliver auxiliary ambulance services, providing national surge capacity of at least 5,000 hours per month as needed to support the ambulance response during periods of increased pressure, allowing National Health Service ambulance crews to respond to emergency calls.</p><p> </p> answering member constituency Newark answering member printed Robert Jenrick question first answered 27/09/2022 13:36:26 answering member 4320 label Biography information for Robert Jenrick
	tabling member	1487 label Biography information for Mr Tobias Ellwood

1503584

	registered interest
	date	02/09/2022
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Drugs: Labelling
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the efficacy of standardising colour coding of capsules between manufacturers to help patients ensure that they are taking the correct medicine.
	tabling member constituency	St Albans
	tabling member printed	Daisy Cooper
	uin	45298
	answer	answer is ministerial correction date of answer 29/09/2022 answer text <p>Regulatory guidance published since 2015 recognises the issue of tablet colour in treatment compliance and encourages suppliers and manufacturers to produce generic versions which are visually aligned with the innovator product.</p> answering member constituency Newark answering member printed Robert Jenrick question first answered 29/09/2022 14:19:37 answering member 4320 label Biography information for Robert Jenrick
	tabling member	4769 label Biography information for Daisy Cooper

1503607

	registered interest
	date	02/09/2022
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Allergies: Medical Equipment
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what recent assessment he has made of the adequacy of supply of EpiPen/epinephrine; and what steps his Department takes to help ensure sufficient supply of that medication.
	tabling member constituency	Plymouth, Moor View
	tabling member printed	Johnny Mercer
	uin	45331
	answer	answer is ministerial correction date of answer 27/09/2022 answer text <p>Epipen 300 microgram pens and Epipen 150 microgram Epipens continue to be available and alternative brands of adrenaline auto-injectors also remain available.</p> answering member constituency Newark answering member printed Robert Jenrick question first answered 27/09/2022 15:33:48 answering member 4320 label Biography information for Robert Jenrick
	tabling member	4485 label Biography information for Johnny Mercer

1503783

	registered interest
	date	02/09/2022
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Infectious Diseases: Disease Control
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, through which consultation process or processes, have (a) relevant stakeholders and (b) members of the public been given the opportunity to contribute to the UK’s position on the World Health Organization’s new international agreement on pandemic preparedness and response; and if he will publish a list of participants.
	tabling member constituency	Cynon Valley
	tabling member printed	Beth Winter
	uin	45483
	answer	answer is ministerial correction date of answer 27/09/2022 answer text <p>The United Kingdom is engaging with a range of stakeholders on the instrument, through roundtables with civil society and discussion with relevant groups. Non-state actors had the opportunity to present views on the working draft of the instrument at recent meetings of the Intergovernmental Negotiating Body, the Member State-led process for drafting and negotiating the pandemic instrument. The World Health Organization (WHO) is holding public hearings seeking input from interested parties, including the public. We will continue engaging relevant stakeholders as it progresses.</p> answering member constituency Newark answering member printed Robert Jenrick question first answered 27/09/2022 13:44:35 answering member 4320 label Biography information for Robert Jenrick
	tabling member	4809 label Biography information for Beth Winter

1503840

	registered interest
	date	02/09/2022
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Ambulance Services: Standards
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what recent (a) steps his Department has taken and (b) research his Department has commissioned to understand the (i) causes and (ii) potential solutions of the pressures being experienced by NHS Ambulance Trusts; and how much funding was allocated to that work.
	tabling member constituency	Twickenham
	tabling member printed	Munira Wilson
	uin	45428
	answer	answer is ministerial correction date of answer 27/09/2022 answer text <p>The Department funds research through the National Institute for Health and Care Research (NIHR). The NIHR welcomes funding applications for research into any aspect of human health including ambulance services. While the NIHR do not usually ring-fence funds for expenditure on particular topics, research proposals in all areas compete for the funding available. Since April 2017, there have been 15 research projects on ambulance services with combined funding of £12,513,665.</p><p>NHS England has allocated an additional £150 million for ambulance service pressures in 2022/23, supporting improvements to response times through additional call handler recruitment, retention and other funding requirements. This is further to a £20 million investment to upgrade the ambulance fleet, which aims to increase ambulance capacity by reducing the age profile of the fleet, increasing productivity and the size of the fleet while decreasing emissions.</p><p>Additionally, St John Ambulance has been contracted to deliver auxiliary ambulance services, providing national surge capacity of at least 5,000 hours per month as needed to support the ambulance response during periods of increased pressure, allowing NHS ambulance crews to focus on responding to emergency calls. Ambulance trusts receive continuous central monitoring and support from the NHS England’s National Ambulance Coordination Centre.</p> answering member constituency Newark answering member printed Robert Jenrick question first answered 27/09/2022 13:37:44 answering member 4320 label Biography information for Robert Jenrick
	tabling member	4776 label Biography information for Munira Wilson